News
Chasing $80bn sales target, AZ unveils $3.5bn US investment
AstraZeneca plans to invest a whopping $3.5 billion to expand its R&D and manufacturing operations in the US by 2026, as part of a drive to raise its revenues to $80 billion by the end
